Latest Breaking News On - Editorial director greg - Page 1 : comparemela.com

TELIX s [ASX:TLX] Gains in the Year Halved as Sell-Off Continues

TELIX s [ASX:TLX] Gains in the Year Halved as Sell-Off Continues
moneymorning.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneymorning.com.au Daily Mail and Mail on Sunday newspapers.

Christian behrenburchTelix pharmaceuticalsManaging directorMiddle eastMoney morning editorsEditorial director gregRoyal dividend

Australia s Energy (Not Climate) Emergency - Money Morning Australia

Australia s Energy (Not Climate) Emergency - Money Morning Australia
moneymorning.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneymorning.com.au Daily Mail and Mail on Sunday newspapers.

South koreaNew south walesWestern australiaBulwer islandGreg canavanViva energyEditorial director gregNet zeroWorld climate declarationIndustrial revolutionHard timesClyde refineryKurnell refineryBulwer island refineryKwinana refineryAltona refinery

Australia s Energy (Not Climate) Emergency - Daily Reckoning Australia

Australia s Energy (Not Climate) Emergency - Daily Reckoning Australia
dailyreckoning.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyreckoning.com.au Daily Mail and Mail on Sunday newspapers.

Bulwer islandNew south walesWestern australiaSouth koreaChris bowenRob parkerJaiden morrisonCory bernardiGreg canavanIan plimerViva energyEditorial director gregNet zeroWorld climate declarationIndustrial revolutionHard times

Emyria [ASX:EMD] Recruits First Patients in Ecstasy Drug Trial for PTSD

Clinical drug development company Emyria Ltd has announced the beginning of phase 2B recruitment of patients for an MDMA-assisted clinical PTSD trial after Australia recently rescheduled the drug.

Greg canavanAndrew forrestDrug administrationEmyria ltdPax centreTherapeutic goods administrationBreakthrough therapy designationRoyal dividend portfolioEditorial director greg